The Negative Impact of Imatinib Mesylate Therapy Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Chronic Myeloid Leukemia

Khalid Ahmed Al‐Anazi(King Faisal Specialist Hospital & Research Centre), Mahmoud Aljurf(King Faisal Specialist Hospital & Research Centre), Naeem Chaudhri(King Faisal Specialist Hospital & Research Centre), Amal Abdulwahab(King Faisal Specialist Hospital & Research Centre), Mohammad Bakr(King Faisal Specialist Hospital & Research Centre), Amr Nassar(Jouf University), M. Morshid(King Faisal Specialist Hospital & Research Centre), Walid Rasheed(King Faisal Specialist Hospital & Research Centre), Fayza Sharif(King Faisal Specialist Hospital & Research Centre), Pankaj Seth(National Brain Research Centre), Ali S. Alshanqeeti(King Abdulaziz City for Science and Technology), Hamad M Al-Omar(King Faisal Specialist Hospital & Research Centre), Hazzaa Alzahrani(King Faisal Specialist Hospital & Research Centre), Entezam Sahovic(King Faisal Specialist Hospital & Research Centre), Khalid I. Eltayeb(King Faisal Specialist Hospital & Research Centre), Ibraheem Othman(King Fahad Specialist Hospital), A. Hejazi(King Faisal Specialist Hospital & Research Centre), Omar Hezam A Alsultan(King Faisal Specialist Hospital & Research Centre), Zeashan Haider Zaidi(King Faisal Specialist Hospital & Research Centre), S. Abu Jafar(King Faisal Specialist Hospital & Research Centre), Said Mohamed(King Faisal Specialist Hospital & Research Centre), Fahad Almohareb(King Faisal Specialist Hospital & Research Centre), A. Beihani(King Faisal Specialist Hospital & Research Centre)
Clinical Medicine Insights Therapeutics
January 1, 2010
Cited by 1


Related Papers